Skip to content

Medical-device intelligence

Immco Diagnostics, Inc.: FDA clearances and recalls

Research Immco Diagnostics, Inc. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

55 clearance records and 0 recall records in the covered releases, across 1 source company names and 20 product codes. Dated history runs from Oct 19, 1988 to Jun 5, 2018.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

55 matching records
Device / recordCompany in FDA recordSourceSource date
ImmuGlo HEp-2 Elite IFAK172745 · DHNImmco Diagnostics, Inc.510(k)Jun 5, 2018FDA decision date
ImmuLisa Enhanced RNA POL III Antibody ELISAK172078 · NYOImmco Diagnostics, Inc.510(k)Mar 30, 2018FDA decision date
ImmuLisa Enhanced AMA IgG Antibody ELISA; ImmuLisa Enhanced AMA IgA/IgG/IgM Antibody ELISAK163133 · DBMImmco Diagnostics, Inc.510(k)Aug 8, 2017FDA decision date
ImmuLisa Enhanced Gliadin IgA Antibody ELISA, ImmuLisa Enhanced Gliadin IgG Antibody ELISAK163177 · MSTImmco Diagnostics, Inc.510(k)Jul 28, 2017FDA decision date
ImmuLisa Enhanced B2GP1 IgA Antibody ELISA, ImmuLisa Enhanced B2GP1 IgG Antibody ELISA, ImmuLisa Enhanced B2GP1 IgM Antibody ELISA, ImmuLisa Enha…K162788 · MSVImmco Diagnostics, Inc.510(k)Jun 19, 2017FDA decision date
ImmuLisa Enhanced Centromere Antibody ELISAK151559 · LJMImmco Diagnostics, Inc.510(k)Mar 11, 2016FDA decision date
ImmuLisa Enhanced RF IgA Antibody ELISA, ImmuLisa Enhanced RF IgG Antibody ELISA, ImmuLisa Enhanced RF IgM Antibody ELISA, ImmuLisa Enhanced RF A…K143736 · DHRImmco Diagnostics, Inc.510(k)Sep 23, 2015FDA decision date
ImmuLisa Enhanced SS-A (Ro) Antibody ELISA, ImmuLisa Enhanced SS-B (La) Antibody ELISA, ImmuLisa Enhanced Sm Antibody ELISA, ImmuLisa Enhanced RN…K142781 · LLLImmco Diagnostics, Inc.510(k)Mar 31, 2015FDA decision date
IMMULISA ENHANCED CELIAC FUSION (TTG/DGP) IGA/IGG ANTIBODY ELISAK123713 · MVMImmco Diagnostics, Inc.510(k)Oct 25, 2013FDA decision date
IMMULISA ENHANCED (TM) CARDIOLIPIN IGA, IGG, IGM AND IGA/IGG/IGM ANTIBODY (ACA) ELISASK113020 · MIDImmco Diagnostics, Inc.510(k)Oct 25, 2012FDA decision date
IMMULISA SCI-70 ANTIBODY ELISAK113143 · LLLImmco Diagnostics, Inc.510(k)Dec 2, 2011FDA decision date
IMMULISA DSDNA ANTIBODY ELISAK101319 · LRMImmco Diagnostics, Inc.510(k)Dec 9, 2010FDA decision date
IMMULISA MPO ANTIBODY ELISAK092599 · MOBImmco Diagnostics, Inc.510(k)Oct 7, 2010FDA decision date
IMMULISA PR3 ANTIBODY ELISAK092600 · MOBImmco Diagnostics, Inc.510(k)Oct 7, 2010FDA decision date
IMMULISA ANCA SCREEN ELISAK092601 · MOBImmco Diagnostics, Inc.510(k)Oct 7, 2010FDA decision date
IMMULISA CELIAC TTG IGA AND IGG ANTIBODY ELISAK091520 · MVMImmco Diagnostics, Inc.510(k)Mar 10, 2010FDA decision date
IMMULISA CELIAC G+ (GLIADIN) IGA AND IGG ANTIBODY ELISAK091522 · MSTImmco Diagnostics, Inc.510(k)Feb 4, 2010FDA decision date
IMMULISA INTRINSIC FACTOR ANTIBODY ELISAK071346 · LIGImmco Diagnostics, Inc.510(k)Sep 24, 2007FDA decision date
IMMUGLO ANTI-ENDOMYSIAL ANTIBODY IFAK060157 · MVMImmco Diagnostics, Inc.510(k)May 25, 2006FDA decision date
IMMULISA ANTINUCLEAR ANTIBODY SCREEN ELISAK041102 · LJMImmco Diagnostics, Inc.510(k)Oct 26, 2004FDA decision date
IMMULISA ANTI-SACCHAROMYCES CEREVISIAE ANTIBODY (ASCA) (IGG)K032850 · NBTImmco Diagnostics, Inc.510(k)Mar 18, 2004FDA decision date
IMMULISA ANTI-SACCHAROMYCES CEREVISIAE ANTIBODY (ASCA) (IGA)K032860 · NBTImmco Diagnostics, Inc.510(k)Mar 18, 2004FDA decision date
IMMULISA ANTI-HUMAN TISSUE TRANSGLUTAMINASE (HU-TTG) ANTIBODY TOTAL IGA/IGG ELISAK040095 · MVMImmco Diagnostics, Inc.510(k)Mar 5, 2004FDA decision date
IMMULISA ANTI-HUMAN TISSUE TRANSGLUTAMINASE (HU-TTG) ANTIBODY IGA ELISAK032571 · MVMImmco Diagnostics, Inc.510(k)Dec 24, 2003FDA decision date
IMMULISA ANTI-BETA2 GLYCOPROTEIN I (B2GP1) IGG ELISAK030701 · MSVImmco Diagnostics, Inc.510(k)Sep 9, 2003FDA decision date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗